Member Info for xviolet

So...there's a new trial booked on Clinical.Gov website in US.

No RNS.

So...that's exciting. Hopefully they've got a grant or someone to help fund it.

Is that sort of where we are....

Could be good

Thanks Tyke

I was thinking of thinking about something from a couple of years ago - re medical device regulations but I must confess I am not particularly up to date on the various moves of IBAI atm. Perhaps its time I went back over the RNS's....

Been a year since the last one

be nice to see some news - anything due re FDA?

JV more probable. perhaps.

unless it was one of us who made the offer.

A large buy? that would be good

I was thinking this was frozen because no one with real £ was buying in the open market.

Very unlikely a small cap pharma will pay for its own p3.

previously - and according to Tim - there has been a relationship with a larger funding partner.

they don't seem to be in a rush. and beyond that we know very little.

some of us adjust our stakes and appetite for risk/loss according to what we know and see. and then go off and enjoy our Sunday. I shall be taking a nice walk around North London, look at the sun in the trees and visit some friends for dinner. and hope everyone else here is fortunate enough to be in a position where they can enjoy the rest of the day.

Just noticed that I'm in profit (on recent buys)

haven't seen that for a while here.

don't sell I guess....maybe more 2 come.

There was a day or two - I can't remember if it was just one day or several- but anyway just b4 the recent war started there was at least one day of very high volume trading on here - as if news was about to break.

Cat/bag

I can't be bothered to take profits.

Been too troubled by war in Iran.

Can't be fxcked to care about a few quid.

Private/admin?

I think the company has languished and survived with very little cash in the past.

current mcap just over £1.3 million acc to LSE.

if I didn't have a day-job I'd be pouring over the figures and wondering about the probability of someone injecting some £.

I buy the odd tranche with pocket money but that doesn't really count for much.

Silver discoveries are quite rare - apparently.

often private - like San Cristobal - that one was private?

so if there's a major silver discovery here. that is quite something.

there are some other things to take into account re investment case on UFO but could all be dwarfed by the facts of a discovery (if that comes).

Maybe they weren't trying to sell that many? I have no idea what they were up to but perhaps they never intended to shift many units.

Is there a breakdown somewhere of exactly how much they spent on this marketing and sales drive? I guess that would tell us something.

As expected.

I still don't know why they didn't just dump or destroy the stock. This was never going to be a winner. Perhaps they have their reasons.

For me the value is another licensing deal. Get that and everything is sunny. Just a bit weird to go from research to retail - it can be done but perhaps its a very slow process.

Raise?

A company should raise when it does not need to raise. I would.

Then you get better terms.

I wouldn't go to the markets or the city if I was on my knees. I'm sure we've all seen those kinds of raises/discounts.

Best time to raise money IMO? When you don't need it.

I wonder if Tim is sitting on something. I don't think the 'big' news re P140 is imminent but enough time has passed since people went into the data room to get a little something. Like a MOU to explore just one auto-immune indication. So not a big deal but a small, exploratory project - and if that project is with a big name pharma, things will move here.

Every time we speak or communicate with others is an opportunity to be honest. And kind. And you must forgive yourself for all the times, in your life, you have been dishonest and unkind. I would like to thank the general tone of this board (and others) for reminding me of this. LSE you show me the light.

Paper in a journal/NDAs - re Roger's interesting (to me) point.

It is normal behavior for a company or for scientists to publish in a peer reviewed journal. But IMM don't seem to be in a hurry about this. I don't know how other commercial (like IMM) companies handle the tension (if there is one) between NDA's with potential partners and disclosure in a journal. Its one more area that for me - as someone who doesn't have a b/g in pharma - has to say 'I don't know'.

May as well look at the charts

or just tune out and wait for the p140 update - probably not for a while.